期刊文献+

吗啡经蛛网膜下腔植入式输注系统治疗晚期癌痛的临床观察 被引量:2

Infusion of morphine by subarachnoid space implantable pump in the treatment of patients with advanced cancer pain
原文传递
导出
摘要 目的观察经蛛网膜下腔植入式输注系统输注吗啡在晚期癌痛患者镇痛的疗效。方法晚期癌痛住院患者25例,通过蛛网膜下腔植入式输注系统输注吗啡镇痛,观察治疗前与吗啡输注后24h、72h、1周、1月的VAS评分、睡眠质量(Qs)、毒副反应。结果1月后疼痛控制程度达优者22例(88%),良1例(4%),一般1例(4%),差1例(4%);优良率为92%。睡眠质量优22例(88%),良3例(12%)。毒副反应有皮肤瘙痒2例(8%),恶心3例(12%),便秘3例(12%),尿潴留4例(16%),未见嗜睡和呼吸抑制者。结论经蛛网膜下腔植入式输注系统输注吗啡对晚期癌痛患者的镇痛疗效确切,不良反应少。 Objective To observe the efficacy of subarachnoid space implantable morphine pump in patients with advanced cancer pain. Methods Twenty-five patients with advanced cancer pain were treated by continuous infusion of morphine with subarachnoid space implantable morphine pump. The analgesic efficacy was evaluated with visual analogue scale, sleeping quality and side reac- tions at pre-treatment and 24, 72 h, 7days and one month after the treatment. Results After a month, the efficacy of 22 cases (88%) was excellent, 1 case (4%) good, 1 case (4%) effective and 1 case (4%) poor. The excellent and good rates were 92%. Excellent quality of sleep was in 22 cases (88%), good was in 3 eases (12M). The side reactions included skin itching in 2 cases (8%), nau- sea in 3 cases (12%), constipation in 3 cases (12%), urinary retention in 4 cases (16%), no lethar gy and respiratory depression. Conclusion With less side-reactions, the effect of suharachnoid implanted morphine pump in the treatment of patients with advanced cancer pain is definite.
出处 《实用疼痛学杂志》 2010年第3期175-177,共3页 Pain Clinic Journal
关键词 蛛网膜下腔 吗啡 输注泵 植入型 肿瘤 疼痛 镇痛 Suharaehnoid Space Morphine Infusion Pumps, Implantabe Neoplasms Pain Analgesia
  • 相关文献

参考文献8

二级参考文献9

  • 1梁伟民,唐辉毅,曹同瓦,徐振邦.经埋藏式硬膜外腔给药系统应用吗啡治疗癌痛[J].临床麻醉学杂志,1994,10(4):208-209. 被引量:4
  • 2史计月,张方林,谷俊霞,张洪林,安静.芬太尼静滴用于术后镇痛的可行性观察[J].山东医药,2005,45(24):15-16. 被引量:8
  • 3[1]Hurstvert O, Maurset A, Qye I. Interaction of the chiral forms of ketamine with opioid, phency clidine, and muscar in icreceptors. Pharmacology and Toxicology, 1995,77: 355 ~ 359.
  • 4[2]Kong PE, Sni Jdelar DG, Crui BJ. Parenteral administration of low dose ketamine for the treatment of neuropathic pain in cancer patients. Ned Ti jdschr Geneeskd, 2002, 146: 2556 ~ 2558.
  • 5[3]Hustvert O, Maurset A, Qye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, and muscarinic receptors. Pharmacology and Toxicology, 1995, 77: 355 ~ 359.
  • 6Mercaante S. Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer, 1999, 85:1849-1858.
  • 7郭志荣,李玉华,李树人.多次硬膜外阻滞1042例次效果分析[J].中华麻醉学杂志,1997,17(2):114-115. 被引量:8
  • 8张惠兰 陈荣秀.肿瘤护理学[M].天津:天津科学技术出版社,2002.381.
  • 9曹伟华,蔡泽玲,黄少卿,陈素钻,曾怀端.口服吗啡用于晚期癌症止痛的家居实践[J].中国肿瘤临床,2003,30(5):331-333. 被引量:17

共引文献44

同被引文献13

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部